Vancomycin Removal During High-Volume Peritoneal Dialysis in Acute Kidney Injury Patients: A Prospective Cohort Clinical Study
Open Access
- 27 September 2018
- journal article
- research article
- Published by Elsevier in Kidney International Reports
- Vol. 4 (1) , 112-118
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Peritoneal Dialysis in Acute Kidney Injury: Brazilian ExperiencePeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2012
- Simultaneous and Direct Determination of Vancomycin and Cephalexin in Human Plasma by Using HPLC-DAD Coupled with Second-Order Calibration AlgorithmsJournal of Analytical Methods in Chemistry, 2012
- Sepsis and Acute Kidney InjuryJournal of the American Society of Nephrology, 2011
- Dialytic Treatment for Septic Patients with Acute Kidney InjuryKidney and Blood Pressure Research, 2011
- Antibiotic dosing in critical illnessJournal of Antimicrobial Chemotherapy, 2011
- How to Optimize Drug Delivery in Renal Replacement TherapySeminars in Dialysis, 2011
- Recent changes in vancomycin use in renal failureKidney International, 2010
- The Pharmacokinetic and Pharmacodynamic Properties of VancomycinClinical Infectious Diseases, 2006
- Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis*Critical Care Medicine, 2006
- Proliferative responses observed following vancomycin treatment in renal proximal tubule epithelial cellsToxicology in Vitro, 2004